Platform Presentations, Endothelial Phd2 Deficiency Impairs Endothelial-Dependent Relaxation And Promotes Coronary, International Vascular Biology Meeting - IVBM, Amsterdam, Netherlands | 07/2024 |
State/Local Invited Seminars/Lectures, P53 acetylation in cardiac fibrosis microvascular dysfunction, and heart failure in mice, Department of Pharmacology, Department of Pharmacology, UMMC | 02/2024 |
Poster Presentation, Deficiency Of Sirtuin 3 In Endothelium Reduces Endothelial-Dependent Relaxation And Impairs Myogenic Response In Coronary And Middle Cerebral Arteries Of Mice., AHA, Philadelphia. PA | 11/2023 |
Poster Presentation, Endothelial Phd2 Deficiency Promotes Angiotensin-Ii-Induced Arterial Stiffness And Coronary Microvascular Dysfunction., NAVB, Newport, Ri | 10/2023 |
Poster Presentation, Treatment with PFKFB3 inhibitor potentially improves diastolic function and arterial stiffness in PHD2ECKO mice., APS Physiology, Long Beach, LA | 04/2023 |
State/Local Invited Seminars/Lectures, Sex differences of endothelial Sirt3 in Angiotensin-II induced perivascular fibrosis and cardiac dysfunction., Department of Pharmacology, Department of Pharmacology, UMMC | 02/2023 |
Platform Presentations, Sex differences of endothelial Sirt3 in Angiotensin-II induced perivascular fibrosis and cardiac dysfunction, External Advisory Board (EAC) meeting, UMMC | 09/2022 |
Poster Presentation, Ferrostatin-1 Ameliorates Cardiac Dysfunction in a Cardiomyocyte-Specific SIRTUIN 3 Knockout Mouse Model., AHA hypertension meeting, San Diego, CA | 09/2022 |
Poster Presentation, Regulatory Role Of Endothelial Phd2 On Hypertensive Arterial Stiffness And Vascular Calcification. Vascular Discovery: From Genes to Medicine, Scientific Sessions, Seattle, WA | 05/2022 |
Poster Presentation, Treatment with PFKFB3 inhibitor potentially improves diastolic function and arterial stiffness in PHD2ECKO mice., APS Physiology, Long Beach, LA | 04/2022 |
Poster Presentation, Novel Regulatory Role Of SIRT3 On Cardiomyocyte Mitochondrial Frataxin And Ferroptosis., Experimental Biology Meeting, Philadelphia, PA | 04/2022 |
State/Local Invited Seminars/Lectures, Sirt3 deficiency in blood pressure, diastolic dysfunction, and renal fibrosis. Department of Pharmacology, Department of Pharmacology, Department of Pharmacology, UMMC | 02/2022 |
Platform Presentations, DEFICIENCY OF SIRTUIN3 DISRUPTS ENDOTHELIAL GLUCOSE METABOLISM AND SENSITIZES PRESSURE OVERLOADINDUCED HEART FAILURE, AHA Scientific sessions, philadelphia, PA | 11/2019 |
Platform Presentations, Role of p53 acetylation in mediating myocardial angiogenesis and diabetic cardiomyopathy., AHA BCVS meeting, Boston, MA | 08/2019 |
Poster Presentation, Deficiency of sirtuin 3 accentuates angiotensin ii-induced arterail stiffness/myocardial fibrosis and hypertension., Experimental Biology, Orlando, Florida | 04/2019 |
Platform Presentations, regulatory role of endothelial sirt3 on blood pressure and diastolic dysfunction in a female mice., AHA council on hypertension, Chicago, IL | 09/2018 |
Poster Presentation, ablation of endothelial sirt3 exacerbates pressure overload-induced heart failure., AHA BCVS meeting, San Antonio | 08/2018 |
Platform Presentations, Sirtuin 3 attenuates diabetic cardiomyopathy via suppression of p53 acetylation and regulating cardiomyocyte metabolism., Experimental Biology, San Diego | 04/2018 |
Poster Presentation, Deletion of endothelial Sirt3 causes diastolic dysfunction, AHA council on hypertension, San Francisco, CA | 09/2017 |
Poster Presentation, Treatment with Prolyl Hydroxylase Inhibitor Reverses Pre-Existing Diastolic Dysfunction in the Aged SIRT3 Knockout Mice, EB meeting, Chicago | 04/2017 |
Poster Presentation, Deletion of Endothelial Sirt3 Causes Coronary Microvascular Dysfunction and HFpEF., Experimental Biology, San Diego, CA | 04/2016 |
Poster Presentation, Sirt3 regulates oxygen sensors and blood vessel formation in the heart., AHA, New Orleans, LA | 09/2013 |
Platform Presentations, Sirt3 is essential for apelin-gene therapy mediated cardiac repair in post-myocardial infarction of diabetes., AHA meeting, New orleans | 09/2013 |
Poster Presentation, SIRT3 Deficiency Impairs Hypoxic Signaling, Reprograms Basal Glycolytic Metabolism and Exacerbates Myocardial Ischemic Injury, Experimental Biology, Boston, MA | 04/2013 |
Poster Presentation, Apelin-13 Increases Myocardial Progenitor Cells and Improves Myocardial Remodeling of Post-myocardial, AHA meeting, New orleans | 09/2012 |
Poster Presentation, Apelin Reduces Myocardial Infarction Size and Promotes Angiogenesis by Increasing SDF-1/CXCR4 and AKT/eNOS/VEGF pathways, AHA meeting, Dallas | 07/2012 |
Poster Presentation, Regulation Of Sirt3 And Autophagy By Bone Marrow Cells Therapy Improves Cardiac Repair In Post-myocardial Infarction Mice, AHA meeting, Dallas | 07/2012 |
Poster Presentation, Ang-1 reduces myocardial infarction via upregulation of SDF-1/CXCR4 and recruiting hematopoietic progenitor cells in the diabetic db/db mouse model., AHA meeting, Orlando, FL | 11/2011 |
Platform Presentations, Hypoxia/reoxygenation-induced myocardial angiogenesis: Role of NADPH oxidase derived reactive oxygen species (ROS), AHA meeting, CIRCULATION 114: 155-155; 2006., AHA meeting, Chicago | 11/2006 |
Poster Presentation, Role of NADPH oxidase-derived reactive oxygen species (ROS) in angiopoietin-1-induced angiogenesis, FASEB JOURNAL 18: A385-A385; 2004., EB meeting, Washington DC | 03/2004 |